"Tumor Suppressor Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development.
Descriptor ID |
D025521
|
MeSH Number(s) |
D12.776.624.776
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tumor Suppressor Proteins".
Below are MeSH descriptors whose meaning is more specific than "Tumor Suppressor Proteins".
This graph shows the total number of publications written about "Tumor Suppressor Proteins" by people in this website by year, and whether "Tumor Suppressor Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2013 | 3 | 0 | 3 |
2014 | 1 | 1 | 2 |
2015 | 0 | 2 | 2 |
2016 | 2 | 0 | 2 |
2018 | 3 | 0 | 3 |
2019 | 3 | 0 | 3 |
2021 | 1 | 1 | 2 |
2022 | 1 | 1 | 2 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Suppressor Proteins" by people in Profiles.
-
Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease. Alzheimers Res Ther. 2023 05 06; 15(1):92.
-
Clonal Elimination of the Pathogenic Allele as Diagnostic Pitfall in SAMD9L-Associated Neuropathy. Genes (Basel). 2022 12 14; 13(12).
-
Phenotype diversity associated with TP63 mutations. J Dtsch Dermatol Ges. 2022 06; 20(6):872-875.
-
TP63-related disorders: two case reports and a brief review of the literature. Dermatol Online J. 2021 Nov 15; 27(11).
-
Familial cleft tongue caused by a unique translation initiation codon variant in TP63. Eur J Hum Genet. 2022 02; 30(2):211-218.
-
p63 establishes epithelial enhancers at critical craniofacial development genes. Sci Adv. 2019 05; 5(5):eaaw0946.
-
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast Cancer Res. 2019 04 29; 21(1):55.
-
Deletions and loss-of-function variants in TP63 associated with orofacial clefting. Eur J Hum Genet. 2019 07; 27(7):1101-1112.
-
BRCA1 and BARD1 mediate apoptotic resistance but not longevity upon mitochondrial stress in Caenorhabditis elegans. EMBO Rep. 2018 12; 19(12).
-
BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells. Brain. 2018 08 01; 141(8):2299-2311.